Ropinirole in a Child With Attention-Deficit Hyperactivity Disorder and Restless Legs Syndrome
Eric Konofal, Isabelle Arnulf, Michel Lecendreux, and Marie-Christine
Mouren
Pediatr Neurol 1 May 2005 32(5): p. 350. highwire.stanford.edu
Service de Psychopathologie de l'Enfant et de l'Adolescent, Hôpital Robert Debré, Paris, France.; Fédération des Pathologies du Sommeil, Hôpital Pitié Salpêtrière, Paris, France
A 6-year-old male being treated with limited efficacy by methylphenidate immediate release for attention-deficit hyperactivity disorder also presented with sleep disruption due to potential restless legs/periodic limb movement syndrome. Treatment with the dopamine agonist ropinirole resulted in a significant improvement in both his attention-deficit hyperactivity disorder symptoms and sleep problems